DC-HIL+CD14+HLA-DRno/lowcells are a potential blood marker and therapeutic target for melanoma

Jake Turrentine, Jin Sung Chung, Kaveh Nezafati, Kyoichi Tamura, Amy Harker-Murray, James F Huth, Rohit Sharma, David B. Harker, Kiyoshi Ariizumi, Ponciano D Cruz

Research output: Contribution to journalLetterpeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'DC-HIL<sup>+</sup>CD14<sup>+</sup>HLA-DR<sup>no/low</sup>cells are a potential blood marker and therapeutic target for melanoma'. Together they form a unique fingerprint.